BA
Bridgewater Advisors’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.55M | Sell |
64,753
-840
| -1% | -$20.1K | 0.12% | 92 |
|
|
2025
Q1 | $1.56M | Sell |
65,593
-306
| -0.5% | -$7.28K | 0.14% | 88 |
|
|
2024
Q4 | $1.74M | Sell |
65,899
-2,777
| -4% | -$73.3K | 0.18% | 67 |
|
|
2024
Q3 | $1.95M | Sell |
68,676
-76
| -0.1% | -$2.16K | 0.2% | 64 |
|
|
2024
Q2 | $2.07M | Buy |
68,752
+4,779
| +7% | +$144K | 0.26% | 58 |
|
|
2024
Q1 | $1.78M | Sell |
63,973
-4,864
| -7% | -$135K | 0.27% | 58 |
|
|
2023
Q4 | $1.98M | Buy |
68,837
+180
| +0.3% | +$5.18K | 0.3% | 50 |
|
|
2023
Q3 | $2.28M | Sell |
68,657
-316
| -0.5% | -$10.5K | 0.37% | 43 |
|
|
2023
Q2 | $2.53M | Sell |
68,973
-84
| -0.1% | -$3.08K | 0.51% | 38 |
|
|
2023
Q1 | $2.82M | Sell |
69,057
-117
| -0.2% | -$4.77K | 0.61% | 36 |
|
|
2022
Q4 | $3.54M | Sell |
69,174
-8,718
| -11% | -$447K | 0.86% | 26 |
|
|
2022
Q3 | $3.41M | Buy |
77,892
+10,574
| +16% | +$463K | 0.94% | 20 |
|
|
2022
Q2 | $3.53M | Buy |
67,318
+200
| +0.3% | +$10.5K | 0.73% | 21 |
|
|
2022
Q1 | $3.48M | Buy |
67,118
+164
| +0.2% | +$8.49K | 0.84% | 24 |
|
|
2021
Q4 | $3.95M | Buy |
66,954
+256
| +0.4% | +$15.1K | 0.87% | 22 |
|
|
2021
Q3 | $2.87M | Buy |
66,698
+6
| +0% | +$258 | 0.79% | 29 |
|
|
2021
Q2 | $2.61M | Buy |
66,692
+968
| +1% | +$37.9K | 0.83% | 28 |
|
|
2021
Q1 | $2.61M | Buy |
+65,724
| New | +$2.61M | 1.32% | 15 |
|
|
2014
Q2 | $906K | Sell |
30,522
-64,239
| -68% | -$1.91M | 0.76% | 41 |
|
|
2014
Q1 | $3.04M | Sell |
94,761
-3,329
| -3% | -$107K | 3.06% | 6 |
|
|
2013
Q4 | $3M | Buy |
+98,090
| New | +$3M | 3.09% | 6 |
|